<s> Two major drug companies posted strong third-quarter earnings , in line with profits already reported by industry leaders and analysts ' expectations . </s>
<s> But Pfizer Inc. , based in New York , reported flat earnings . </s>
<s> Schering-Plough Corp. , based in Madison , N.J. , reported a 21 % rise in earnings as American Home Products Corp. of New York posted an 11 % increase in net . </s>
<s> American Home Products </s>
<s> American Home Products said sales and earnings for the third quarter and nine months were at record levels . </s>
<s> Sales for the third quarter increased 6.5 % to $ 1.51 billion from $ 1.42 billion . </s>
<s> Sales of health-care products increased 6 % in the third quarter , based in part on strong sales of prescription drugs such as Premarin , an estrogen-replacement drug , and sales of the company 's infant formula . </s>
<s> American Home Products said net income benefited from a `` lower effective tax rate , '' reflecting a reduction of foreign tax rates , and additional operations in Puerto Rico . </s>
<s> Net also was aided by a gain on the sale of the company 's equity interests in South Africa effective Sept. 1 . </s>
<s> In New York Stock Exchange composite trading yesterday , American Home Products closed at $ 102.25 a share , down 75 cents . </s>
<s> Pfizer </s>
<s> Pfizer said third-quarter sales increased 4 % to $ 1.44 billion from $ 1.38 billion . </s>
<s> The company said net income was flat because of investment in research and development and costs related to launches of several products . </s>
<s> The company said the dollar 's continued strengthening reduced world-wide sales growth by three percentage points . </s>
<s> Pfizer posted its largest gains in healthcare sales , up 3 % , and consumer products , up 23 % . </s>
<s> Sales by the specialty chemicals and materials science segments were flat , and sales by the agriculture segment declined 5 % . </s>
<s> In the health-care segment , pharmaceutical sales increased 4 % and sales of hospital products increased 1 % . </s>
<s> During the quarter , Pfizer received federal approval of Procardia XL , a calcium channel blocker approved for both angina and hypertension , and Monorail Piccolino , used to open obstructed coronary arteries . </s>
<s> In New York Stock Exchange composite trading yesterday , Pfizer closed at $ 67.75 a share , up 75 cents . </s>
<s> Schering-Plough </s>
<s> Schering-Plough said sales gained 2.7 % to $ 743.7 million from $ 724.4 million . </s>
<s> In the period , the company completed the sale of its European cosmetics businesses , sold a majority interest in its Brazilian affiliate , and announced the reorganization of its over-the-counter drug businesses into a new unit , Schering-Plough Health Care Products . </s>
<s> These actions did n't affect results because the gain on the sale of the European cosmetics businesses was offset by provisions relating to the Brazil divestiture and drug restructuring . </s>
<s> U.S. pharmaceutical sales rose 15 % , led by allergy , asthma and cold products ; dermatological products ; anti-infectives and anti-cancer products ; and cardiovascular products . </s>
<s> World-wide consumer product sales declined 12 % , primarily because of the European cosmetics sale . </s>
<s> Significantly lower sales of ` Stay Trim ' diet aids also were a factor in the drop . </s>
<s> The Maybelline beauty product line had higher sales following a sluggish first half . </s>
<s> In Big Board composite trading , Schering-Plough shares fell 75 cents to close at $ 74.125 . </s>
